GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Wuzhong Pharmaceutical Development Co Ltd (SHSE:600200) » Definitions » Receivables Turnover

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Receivables Turnover : 0.66 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jiangsu Wuzhong Pharmaceutical Development Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Jiangsu Wuzhong Pharmaceutical Development Co's Revenue for the three months ended in Mar. 2024 was ¥703 Mil. Jiangsu Wuzhong Pharmaceutical Development Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥1,061 Mil. Hence, Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover for the three months ended in Mar. 2024 was 0.66.


Jiangsu Wuzhong Pharmaceutical Development Co Receivables Turnover Historical Data

The historical data trend for Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Wuzhong Pharmaceutical Development Co Receivables Turnover Chart

Jiangsu Wuzhong Pharmaceutical Development Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.22 3.05 2.45 2.50 2.48

Jiangsu Wuzhong Pharmaceutical Development Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.52 0.37 0.70 0.66

Competitive Comparison of Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover

For the Biotechnology subindustry, Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover falls into.



Jiangsu Wuzhong Pharmaceutical Development Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=2239.963 / ((859.316 + 948.796) / 2 )
=2239.963 / 904.056
=2.48

Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

Receivables Turnover (Q: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2024 ) / ((Accounts Receivable (Q: Dec. 2023 ) + Accounts Receivable (Q: Mar. 2024 )) / count )
=703.371 / ((948.796 + 1172.532) / 2 )
=703.371 / 1060.664
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Wuzhong Pharmaceutical Development Co  (SHSE:600200) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Jiangsu Wuzhong Pharmaceutical Development Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Jiangsu Wuzhong Pharmaceutical Development Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Business Description

Traded in Other Exchanges
N/A
Address
110 North Road, Soochow 7,8,10 Bank of China Building, Suzhou, Jiangsu, CHN, 215128
Jiangsu Wuzhong Industrial Co Ltd is a China-based company. It develops, produces and sells medicines while engages in real estate development.
Executives
Xu Liang Zhi senior management
Sun Jian Ying Supervisors
Zhong Yao Wen Supervisors
Cheng Xi senior management
Wu Jian Min Supervisors
Zhao Wei Yi Director
Jin Li Director
Sun Tian Jiang senior management
Zhu Ju Fang senior management
Yao Jian Lin Director
Jin Jian Ping Supervisors
Li Gui Zhi Supervisors
Luo Qin Supervisors
Xia Jian Ping Director
Zhong Shen Zheng Director

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Headlines

No Headlines